Coastar Therapeutics Inc.
Monday, February 26, 2024
Coastar Therapeutics is a venture-backed biotech company based in San Diego, CA, focused on next generation gene delivery technology. The company has developed a novel ENHEnS application that can coat human cell membrane on each individual virus to evade immune system recognition and clearance. Coastar also developed an eLNP application with the cell membrane for non-viral gene delivery. Our technology enables repeated injection and targeted gene delivery for viral and non-viral gene therapies.
CEO/Top Company Official
Lead Product in Development
CTX001 is a cell membrane coated virus that can enter and kill cancer cells as well as express a cytokine to boost the immune system response to tumor. The company is moving this program to phase I clinical trial in Australia targeting advanced melanoma and triple negative breast cancer.
Development Phase of Primary Product